IGEA Pharma N.V. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was EUR 0.1033 million compared to EUR 0.1237 million a year ago. Net loss was EUR 1.25 million compared to EUR 0.9989 million a year ago.

Basic loss per share from continuing operations was EUR 0.004 compared to EUR 0.0032 a year ago. Diluted loss per share from continuing operations was EUR 0.004 compared to EUR 0.0032 a year ago.